Monday 28th of February is Rare Disease Day, and NF2 Biosolutions will raise funds to sponsor a new approach for tackling Neurofibromatosis type 2. This approach is called Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes, it is a type of novel immunotherapy that has been used and it’s effective in other cancers. On Monday we will also hold a webinar where Dr. Claire O’Leary will explain the objective of this project and how immunotherapy could be the answer to NF2 mutations.
We are delighted to present our first ever NF2 showcase webinar in partnership with One Nucleus on air on Friday February 4th 2022 at 12noon (GMT).
NF2 BioSolutions UK CEO Clare Goddard and One Nucleus CEO Tony Jones present and invite you to our showcase featuring charity trustee and world-renowned NF2 expert Prof. Gareth Evans. Then listen to our 2 NF2 PhD researchers Grace and Adam on their NF2 tumour inflammation work, followed by major fundraiser Andy White and his motivation for raising funds and awareness to help end NF2.
Surgical Management of NF2 Tumors: Experts panel discussion with Q&A – Feb 28, 2021 – 12 PM Eastern time (US and Canada) – 17:00 London time, 18:00 Paris/Berlin time
Join NF2 BioSolutions and our esteemed panel of surgeons as we discuss the surgical management of NF2 tumors, including schwannomas, ependymomas, and meningiomas. MORE DETAILS HERE
NF2 BioBank: You can advance NF2 research by donating tumor tissue – Oct 24, 2020 11:00 AM Eastern time (US and Canada) – 16:00 London time
When: Oct 24, 2020 11:00 AM Eastern time (the US and Canada) – 16:00 London time
Understanding NF2: Diagnosis, Management and Challenges
CereXis and NF2 BioSolutions invite you to learn about NF2 from the experts. Our panelists include Dr. D. Bradley Welling, Chief of Otolaryngology-Head and Neck Surgery at Massachusetts Eye and Ear and Prof D Gareth Evans, Professor of Med. Genetics and Cancer Epidemiology, The University of Manchester, UK.
We will hear from Dr. John Mekalanos from Harvard Medical School and Dr. Gary Brenner from Massachusetts General Hospital about how their labs are working with genetically modified bacteria to kill NF2 tumor cells and how you can support this exciting new project!
New hope for NF2 – Gene Therapy 101 – May 22nd, 2020
For our first ever NF2 gene therapy webinar! Chief Scientific Officer Dr. Edgar Rodríguez-Lebrón presents Gene Therapy 101 to give us a better understanding of how gene therapy works and what types of therapies are most promising for curing NF2. You will not want to miss this!